Baird Maintains Outperform on DexCom, Raises Price Target to $240

Baird maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $195 to $240.

Benzinga · 11/07/2019 14:03

Baird maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $195 to $240.